ArticleInternational journal of endocrinology2019

Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes.

Ruo-Yao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.